Two separate lawsuits filed Wednesday provide the latest evidence that the next front in the battle over abortion access will be the availability of medication used to administer abortions.
The cases include a district court challenge from a North Carolina physician who argues that federal regulations should override state laws requiring the abortion drug mifepristone to be dispensed in person in surgical facilities and a mandatory 72-hour waiting period to receive the drug.
The second case, filed by GenBioPro, challenges West Virginia’s ban on most abortions and ban against using telemedicine to prescribe mifepristone.
